Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.

Okuda DT, Moog TM, McCreary MC, Huddleston IJ, Wright CM, Burgess KW, Santoyo JR, Sguigna PV, Stüve O, Tran DH

Open source

DOI
10.1007/s40120-026-01005-y
Published
2026 Aug 14
Container
Neurology and therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-01005-y,
  title = {Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.},
  author = {Okuda DT and Moog TM and McCreary MC and Huddleston IJ and Wright CM and Burgess KW and Santoyo JR and Sguigna PV and Stüve O and Tran DH},
  year = {2026},
  journal = {Neurology and therapy},
  doi = {10.1007/s40120-026-01005-y},
  url = {https://doi.org/10.1007/s40120-026-01005-y}
}

RIS

TY  - JOUR
TI  - Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.
AU  - Okuda DT
AU  - Moog TM
AU  - McCreary MC
AU  - Huddleston IJ
AU  - Wright CM
AU  - Burgess KW
AU  - Santoyo JR
AU  - Sguigna PV
AU  - Stüve O
AU  - Tran DH
PY  - 2026
JO  - Neurology and therapy
DO  - 10.1007/s40120-026-01005-y
UR  - https://doi.org/10.1007/s40120-026-01005-y
ER  - 

APA

DT, O., TM, M., MC, M., IJ, H., CM, W., KW, B., JR, S., PV, S., O, S., & DH, T. (2026). Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.. Neurology and therapy. https://doi.org/10.1007/s40120-026-01005-y

Source records